CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 101,510 enrolled
Drug / intervention
Observational Studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03585400
NCT03585400N/ACompleted

Validation of the REPS Prediction Tool to Improve Quality of Perioperative Care

Beth Israel Deaconess Medical Center·observational·Posted Jul 13, 2018·Updated Jan 26, 2021

In Brief

An observational study evaluating Observational Study for Residual Neuromuscular Blockade and 2 related conditions. Completed, enrolled 101,510 participants across 1 site.

Detailed Summary

Neuromuscular blocking agents' (NMBA) use during surgery is associated with postoperative respiratory complications and increased risk of readmission to the hospital following ambulatory surgery. Residual neuromuscular block (rNMB) after surgery is difficult to identify. We have recently developed the REsidual neuromuscular block Prediction Score (REPS), that predicts the risk for postoperative rNMB. Our primary objective is now to assess the predictive ability of the REPS for respiratory complications within seven days following general anaesthesia. The secondary objective is to compare the predictive values of REPS and train-of-four (TOF)-ratio below 0.90 for respiratory complications.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 13, 2018
Enrollment StartJun 29, 2018
Primary CompletionDec 10, 2019
Study CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.0 years ago

Interventions

Observational Studyother

Observational Study: Not Applicable for Observational Studies